A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease

about

Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.

P2860

Q38667647-968D1360-7904-4762-8095-60A094D7AD36 Q38740848-ACC462E5-B123-43F8-AF53-4D11458F7C70

P2860

A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease

Item

http://www.wikidata.org/entity/Q37184470

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A population approach to chara ...... people and Alzheimer's disease

@en

A population approach to chara ...... eople and Alzheimer's disease.

@nl

type

Item

label

A population approach to chara ...... people and Alzheimer's disease

@en

A population approach to chara ...... eople and Alzheimer's disease.

@nl

prefLabel

A population approach to chara ...... people and Alzheimer's disease

@en

A population approach to chara ...... eople and Alzheimer's disease.

@nl

P1476

A population approach to chara ...... people and Alzheimer's disease

@en

P2093

Akshay Nair

http://www.w3.org/2001/XMLSchema#string

Alan Smith

http://www.w3.org/2001/XMLSchema#string

David Taylor

http://www.w3.org/2001/XMLSchema#string

Emma McLachlan

http://www.w3.org/2001/XMLSchema#string

Robert Howard

http://www.w3.org/2001/XMLSchema#string

Stuart Brownings

http://www.w3.org/2001/XMLSchema#string

Suki Greaves

http://www.w3.org/2001/XMLSchema#string

Suzanne Reeves

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

Prediction of creatinine clearance from serum creatinine

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

P2888

s00213-016-4379-6

P304

3371-3381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-016-4379-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizia D'Antonio

Julie Bertrand

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27481049

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4989015

http://www.w3.org/2001/XMLSchema#string

A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease

about

P2860

P2860

A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932